About Outpace Bio
Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast™), recruit a productive immune response in the tumor microenvironment (OutSmart™), and achieve the potency (OutSpacers™), specificity (Co-LOCKR™), and safety (EGFRopt™) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes.
At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.
|
|
|
51-200 employees
View all Outpace Bio employees
|
|
Biotechnology
|
|
700 Fairview Ave N, Suite 300, Seattle, Washington 98109, US
|
|
2020
|
|
Cell Therapy, Immuno-Oncology, Cytokines, Cell Engineering, Protein Design
|
Outpace Bio Alternatives
Frequently Asked Questions about Outpace Bio
The decision makers in Outpace Bio are Holly Lujan, Bianca Moreno, Brian Weitzner, etc. Click to Find Outpace Bio decision makers emails.
Outpace Bio Staff Directory
Search Outpace Bio Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
